DESCRIPTION
A 30-year-old woman presented with a dull aching pain in the right hypochondrium for 2 years with a history of loss of weight and loss of appetite for 4 months. Clinical examination did not reveal any significant findings. An abdominal ultrasonography revealed a large mass (10.8 cm) arising from the adrenal gland. Further evaluation with a contrastenhanced CT scan showed a well-defined heterogeneously enhancing soft tissue attenuation lesion measuring 12.7×13.3×13.4 cm in the right adrenal gland (figures 1-3) with tumoural thrombosis in the inferior vena cava (IVC; figure 4) extending to the right atrium (figure 5). A whole-body scintigraphy was negative for bone metastases. Plasma levels of cortisol, aldosterone, 17-OH-progesterone, dehydroepiandrosterone sulfate and δ4-androstenedione were normal. A fine-needle aspiration cytology of mass showed findings consistent with adrenocortical carcinoma (ACC; figures 5 and 6). She was advised complete excision of ACC with tumour thrombectomy using cardiopulmonary bypass, but the patient refused surgery. She was given mitotane with three cycles of palliative chemotherapy using cyclophosphamide, doxorubicin and cisplatin. The follow-up after completion of chemotherapy showed partial response with non-progressive tumour thrombus. ACC is a rare malignancy with incidence of 0.5-2 cases/million/year. 1 In ACC, the presence of IVC and atrial invasion is considered as tumour extension and not as a metastatic disease. In such cases, a more aggressive surgical approach may give better results. 2 For patients who are unfit for surgery or who refuse radical surgery, chemotherapy can be tried. To date, mitotane has been the only drug that has proven effective in treating patients with metastatic ACC. 2 The combination of cisplatin, doxorubicin, etoposide and mitotane has produced clinical response rates of about 50% even in advanced cases. 
Learning points
▸ Adrenocortical cancer is a very rare tumour with a poor prognosis. ▸ Inferior vena cava (IVC) thrombus in adrenocortical carcinoma is rare and tumour extension up to the right atrium is an extremely rare finding. ▸ Surgical extirpation is the only curative treatment for large adrenal masses with thrombus extending into the IVC/atrium. ▸ In patients with advanced adrenocortical carcinoma, mitotane is a useful drug. The patients who do not afford mitotane or who do not tolerate mitotane, other chemotherapeutic agents such as cyclophosphamide, doxorubicin and cisplatin can be tried. 
